Vanguard Group Inc Cv Rx, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Cv Rx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 594,312 shares of CVRX stock, worth $6.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

594,312

Previous 562,592 5.64%

Holding current value

$6.2 Million

Previous $17.7 Million 38.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.99 - $30.49 $570,642 - $967,142	31,720 Added 5.64%	594,312 $10.8 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $33.01 $146,621 - $414,737	12,564 Added 2.28%	562,592 $17.7 Million
Q3 2023 Nov 14, 2023	BUY	$13.56 - $18.47 $23,241 - $31,657	1,714 Added 0.31%	550,028 $8.34 Million
Q2 2023 Aug 14, 2023	BUY	$8.57 - $15.44 $471,187 - $848,906	54,981 Added 11.14%	548,314 $8.47 Million
Q1 2023 May 15, 2023	BUY	$7.08 - $19.4 $326,373 - $894,301	46,098 Added 10.31%	493,333 $4.6 Million

Q4 2022 Feb 10, 2023	BUY	$10.07 - $18.35 $150,194 - $273,690	14,915 Added 3.45%	447,235 $8.21 Million
Q3 2022 Nov 14, 2022	SELL	$6.12 - $9.5 $73,733 - $114,456	-12,048 Reduced 2.71%	432,320 $4.03 Million
Q2 2022 Aug 12, 2022	SELL	$4.7 - $7.22 $91,964 - $141,273	-19,567 Reduced 4.22%	444,368 $2.67 Million
Q1 2022 May 13, 2022	BUY	$5.62 - $12.37 $391,815 - $862,411	69,718 Added 17.69%	463,935 $2.78 Million
Q4 2021 Feb 14, 2022	SELL	$10.65 - $18.61 $3.09 Million - $5.4 Million	-290,074 Reduced 42.39%	394,217 $4.82 Million
Q3 2021 Nov 12, 2021	BUY	$14.65 - $26.07 $9.31 Million - $16.6 Million	635,531 Added 1303.39%	684,291 $11.3 Million
Q2 2021 Aug 13, 2021	BUY	$28.0 - $28.0 $1.37 Million - $1.37 Million	48,760 New	48,760 $1.37 Million

Others Institutions Holding CVRX

# of Institutions

Shares Held

13.8M

Call Options Held

264K

Put Options Held

89.3K

View Full List

About CVRx, Inc.

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $215M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

More about CVRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Cv Rx, Inc. Transaction History